Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $7.0 million.

  • ENvue Medical's Cash & Current Investments rose 43486.59% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 43486.59%. This contributed to the annual value of $752000.0 for FY2024, which is 7709.41% down from last year.
  • According to the latest figures from Q3 2025, ENvue Medical's Cash & Current Investments is $7.0 million, which was up 43486.59% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Cash & Current Investments registered a high of $8.6 million during Q3 2021, and its lowest value of $253000.0 during Q2 2023.
  • Moreover, its 5-year median value for Cash & Current Investments was $3.3 million (2023), whereas its average is $3.8 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 170090.29% in 2021, then plummeted by 9358.52% in 2023.
  • Quarter analysis of 5 years shows ENvue Medical's Cash & Current Investments stood at $7.7 million in 2021, then crashed by 64.93% to $2.7 million in 2022, then rose by 21.01% to $3.3 million in 2023, then tumbled by 77.09% to $752000.0 in 2024, then soared by 828.19% to $7.0 million in 2025.
  • Its Cash & Current Investments stands at $7.0 million for Q3 2025, versus $4.1 million for Q2 2025 and $601000.0 for Q1 2025.